Corporate Corruption Media Articles

Excerpts of Key Corporate Corruption Media Articles in Major Media

Below are key excerpts of revealing news articles on corporate corruption from reliable news media sources. If any link fails to function, a paywall blocks full access, or the article is no longer available, try these digital tools.

Note: Explore our full index to key excerpts of revealing major media news articles on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.

Hoping to prevent Congress from letting the government negotiate lower drug prices for millions of older Americans on Medicare, the pharmaceutical companies have been recruiting Democratic lobbyists [and] lining up allies in the Bush administration and Congress. Many drug company lobbyists concede that the House is likely to pass a bill intended to drive down drug prices, but they are determined to block such legislation in the Senate. If that strategy fails, they are counting on President Bush to veto any bill that passes. With 49 Republicans in the Senate next year, the industry is confident that it can round up the 34 votes normally needed to uphold a veto. They began developing strategy last week at a meeting of the board of the Pharmaceutical Research and Manufacturers of America. Billy Tauzin, president of that group [and] a former congressman...met with Senator Byron L. Dorgan, a North Dakota Democrat who has been trying for six years to allow drug imports from Canada. The industry vehemently opposes such legislation. The 2003 Medicare law prohibits the federal government from negotiating drug prices or establishing a list of preferred drugs. Drug makers have not set a budget for their campaign. They and their trade groups already spend some $100 million a year on lobbying in Washington. Representative Frank Pallone Jr., Democrat of New Jersey [said] “The 2003 Medicare law was essentially written by the drug industry.” Drug companies may be open to some changes in the Medicare drug benefit, but they say they cannot accept any form of price negotiation.

Note: For lots of verifiable information on the power of the drug industry to corrupt Congress, click here.

The most important--and unfortunately the least debated--issue in politics today is our society's steady drift toward a class-based system, the likes of which we have not seen since the 19th century. America's top tier has grown infinitely richer and more removed over the past 25 years. Few among them send their children to public schools; fewer still send their loved ones to fight our wars. They own most of our stocks, making the stock market an unreliable indicator of the economic health of working people. The top 1% now takes in an astounding 16% of national income, up from 8% in 1980. The tax codes protect them, just as they protect corporate America, through a vast system of loopholes. Incestuous corporate boards regularly approve compensation packages for chief executives and others that are out of logic's range. As this newspaper has reported, the average CEO of a sizeable corporation makes more than $10 million a year, while the minimum wage for workers amounts to about $10,000 a year, and has not been raised in nearly a decade. When I graduated from college in the 1960s, the average CEO made 20 times what the average worker made. Today, that CEO makes 400 times as much. Trickle-down economics didn't happen. Wages and salaries are at all-time lows as a percentage of the national wealth. This ever-widening divide is too often ignored or downplayed by its beneficiaries. A sense of entitlement has set in among elites, bordering on hubris.

Note: For some reason the Wall Street Journal has removed this article. You can read it on the website of the article's author at this link.

Investigations led by a Republican lawyer named Stuart W. Bowen Jr. in Iraq have sent American occupation officials to jail on bribery and conspiracy charges, exposed disastrously poor construction work by well-connected companies like Halliburton and Parsons, and discovered that the military did not properly track hundreds of thousands of weapons it shipped to Iraqi security forces. And tucked away in a huge military authorization bill that President Bush signed two weeks ago is what some of Mr. Bowen’s supporters believe is his reward for repeatedly embarrassing the administration: a pink slip. An obscure provision...terminates his federal oversight agency, the Office of the Special Inspector General for Iraq Reconstruction. The clause was inserted by the Republican side of the House Armed Services Committee. It has generated surprise and some outrage among lawmakers who say they had no idea it was in the final legislation. Susan Collins, a Maine Republican who followed the bill closely as chairwoman of the Senate Committee on Homeland Security and Government Affairs, says that she still does not know how the provision made its way into what is called the conference report, which reconciles differences between House and Senate versions of a bill. Neither the House nor the Senate version contained such a termination clause before the conference, all involved agree. Mr. Bowen’s office has 55 auditors and inspectors in Iraq and about 300 reports and investigations already to its credit, far outstripping any other oversight agency in the country.

Diebold Inc. demanded that cable network HBO cancel a documentary that questions the integrity of its voting machines, calling the program inaccurate and unfair. The program, "Hacking Democracy," is scheduled to debut on Nov. 2, five days before the 2006 U.S. midterm elections. The film claims Diebold voting machines aren't tamper-proof and can be manipulated to change voting results. "Hacking Democracy" is "replete with material examples of inaccurate reporting," Diebold Election System President David Byrd said in a letter to HBO President and Chief Executive Officer Chris Albrecht. "We stand by the film," HBO spokesman Jeff Cusson said in an interview. "We have no intention of withdrawing it from our schedule." This is Diebold's second defense of its system since last month. On Sept. 26, Byrd wrote to Jann Wenner, editor and publisher of Rolling Stone, saying a story written by Robert F. Kennedy Jr., "Will the Next Election Be Hacked?" was "error- riddled" and that readers "deserve a better researched and reported article." The documentary is based on the work of Bev Harris of Renton, founder of BlackBoxVoting.org, which monitors election accuracy. Harris says on the HBO Web site that she found "secret program files" used by Diebold for its electronic voting machines. Harris copied them and distributed the programs to others as a way to show the vulnerability of a system designed to safeguard voting, according to the Web site.

Note: For the revealing story in Rolling Stone, click here.

ExxonMobil should stop funding groups that have spread the idea that global warming is a myth and that try to influence policymakers to adopt that view, two senators said today in a letter to the oil company. In their letter to ExxonMobil chairman and CEO Rex Tillerson, Sens. Olympia Snowe, R-Maine, and Jay Rockefeller, D-W.Va., appealed to Exxon's sense of corporate responsibility, asking the company to "come clean about its past denial activities." The two senators called on ExxonMobil to "end any further financial assistance" to groups "whose public advocacy has contributed to the small but unfortunately effective climate change denial myth." An upcoming study from the Union of Concerned Scientists reported that ExxonMobil funded 29 climate change denial groups in 2004 alone. Since 1990, the report said, the company has spent more than $19 million funding groups that promote their views through publications and Web sites that are not peer reviewed by the scientific community.

Several government doctors say drug maker Eli Lilly & Co. subtly orchestrated medical guidelines for treatment of an often lethal blood infection, hoping to boost sales of a drug whose value is being debated. “This company is trying to insinuate its drug into many aspects of patient care that industry really shouldn’t be involved in,” said Dr. Naomi O’Grady, a critical care specialist at the National Institutes of Health. Three of her NIH colleagues claim in Thursday’s New England Journal of Medicine that Lilly worked through medical societies to influence standards for treating the blood infection, sepsis. Ultimately, Xigris was incorporated into the guidelines. Both the guidelines committee and a larger information campaign on sepsis were heavily funded by [Lilly]. Dr. Phil Dellinger, who helped lead the guidelines committee, said...“We’ve been catching grief because we’ve been taking a lot of Lilly money — and we’re appreciative of Lilly giving it.” The U.S. Food and Drug Administration approved Xigris in 2001, despite an evenly split vote by its advisory committee. The lead author of Thursday’s journal article, Dr. Peter Q. Eichacker, voted against approval. Some critics are unhappy that the drug, which works only for the sickest patients, was approved on the basis of a single experiment. Academic officials acknowledged in the published guidelines that Lilly gave more than 90 percent of $861,000 in grants for the campaign and medical recommendations. O’Grady, of NIH, said a panel of disease experts that she headed refused to endorse the sepsis guidelines largely because Lilly “convened the whole panel.”

Note: For lots more on how the powerful pharmaceutical industry endangers our lives, click here.

Almost half of all Americans believe the November elections have more influence than market forces. For them, the plunge at the pump is about politics, not economics. According to a new Gallup poll, 42 percent of respondents agreed with the statement that the Bush administration "deliberately manipulated the price of gasoline so that it would decrease before this fall's elections." Fifty-three percent of those surveyed did not believe in this conspiracy theory, while 5 percent said they had no opinion. The excitement—and suspicion—among U.S. motorists follows a post-summer decline in gasoline prices that even veteran analysts and gas station owners concede has been steeper than usual. The retail price of gasoline has plunged by 50 cents, or 17 percent, over the past month to average $2.38 a gallon nationwide, according to Energy Department statistics. That is 42.5 cents lower than a year ago, when the energy industry was still reeling from the aftermath of hurricanes Katrina and Rita, which damaged petroleum platforms, pipelines and refineries across the Gulf Coast. Fimat USA oil analyst Antoine Halff said there is no doubt that "the downturn in prices is welcome news from an electoral standpoint for the ruling party." But he scoffed at the notion that the U.S. president had the power to muscle around a global market.

Four government auditors who monitor leases for oil and gas on federal property say the Interior Department suppressed their efforts to recover millions of dollars from companies they said were cheating the government. The auditors contend that they were blocked by their bosses from pursuing more than $30 million in fraudulent underpayments of royalties for oil produced in publicly owned waters in the Gulf of Mexico. "The agency has lost its sense of mission, which is to protect American taxpayers," said Bobby L. Maxwell, who was formerly in charge of Gulf of Mexico auditing. "These are assets that belong to the American public, and they are supposed to be used for things like education, public infrastructure and roadways." The lawsuits have surfaced as Democrats and Republicans alike are questioning the Bush administration's willingness to challenge the oil and gas industry. The new accusations surfaced just one week after the Interior Department's inspector general, Earl E. Devaney, told a House subcommittee that "short of crime, anything goes" at the top levels of the Interior Department. In another clash, frustrated federal auditors have complained that the Interior Department no longer allows them to subpoena documents from oil companies. Agency officials acknowledged that they have not issued any subpoenas in the last three years.

Public kept in dark as business leads talks about North American integration. Away from the spotlight, from Sept. 12 to 14, in Banff Springs, Minister of Public Safety Stockwell Day and Defence Minister Gordon O'Connor met with U.S. and Mexican government officials and business leaders to discuss North American integration at the second North American Forum. The guest list included such prominent figures as U.S. Defence Secretary Donald Rumsfeld, Mexican Secretary of Public Security Eduardo Medina Mora and Canadian Forces chief General Rick Hillier. The event was chaired by former U.S. secretary of state George Schultz, former Alberta premier, Peter Lougheed and former Mexican finance minister Pedro Aspe. Organizers did not alert the media about the event. Our government ... refuses to release any information about the content of the discussions or the actors involved. The event was organized by the Canadian Council of Chief Executives. The media have paid little attention to this far-reaching agreement, so Canadians are unaware that a dozen working groups are currently "harmonizing" Canadian and U.S. regulations on everything from food to drugs to the environment and even more contentious issues like foreign policy. This process ... is about priming North America for better business by weakening the impacts of such perceived obstacles as environmental standards and labour rights. This is why the public has been kept in the dark while the business elite has played a leading role in designing the blueprint for this more integrated North America.

Note: If the above link fails, click here. Why has the U.S. media not covered this key topic? For a second article discussing this secret meeting on a top Canadian TV website, click here. To learn about other secret meetings of the power elite, click here

The level of nicotine that smokers typically consume per cigarette has risen 10 percent in the past six years, making it harder to quit and easier to be addicted, said a report that the Massachusetts Department of Health released on Tuesday. The study shows a steady increase in the amount of nicotine delivered to the smokers? lungs regardless of brand, with overall yields increasing 10 percent. Massachusetts is one of three states to require tobacco companies to submit information on nicotine testing to its specifications and is the sole state with data as far back as 1998. The study found that the three most popular brands with young smokers, Marlboro, Newport and Camel, delivered significantly more nicotine than they did six years ago. Nicotine consumed in Kool, a popular menthol brand, rose 20 percent.

A federal judge ruled yesterday that tobacco companies have violated civil racketeering laws, concluding that cigarette makers conspired for decades to deceive the public about the dangers of their product. But U.S. District Judge Gladys Kessler said that under a 2005 appellate court ruling, she could not impose billions of dollars in penalties that had been sought by the Justice Department in its civil racketeering suit. In the opinion...Kessler wrote that there is "overwhelming evidence" [that the industry] conspired to violate, and indeed violated, federal racketeering laws. "In short," she wrote, "defendants have marketed and sold their lethal product with zeal, with deception, with a single-minded focus on their financial success, and without regard for the human tragedy or social costs that success exacted. Over the course of more than 50 years, defendants lied, misrepresented and deceived the American public, including smokers and the young people...about the devastating health effects of smoking and environmental tobacco smoke." Kessler added that the companies "suppressed research, they destroyed documents, they manipulated the use of nicotine so as to increase and perpetuate addiction...and they abused the legal system in order to achieve their goal -- to make money." The Justice Department lawsuit originally sought $280 billion. But the U.S. Court of Appeals [ruled] a company could not be forced to turn over past profits as a way of preventing future misconduct. The Justice Department subsequently proposed a $130 billion penalty to pay for anti-smoking programs, but...it scaled that back to a total of $14 billion.

Medicare's drug benefit has given a shot in the arm to pharmaceutical companies and insurers, whose revenue is climbing thanks to government subsidies for prescription medicine. What's happened so far: Drugmakers including GlaxoSmithKline and Pfizer reported higher-than-expected sales and profit in the second quarter, with some of the momentum coming from Medicare. Meanwhile, membership rolls of big insurers, including UnitedHealth Group and Humana, are mushrooming as Medicare beneficiaries sign up for drug plans. Drug companies -- which successfully thwarted price-control attempts -- are reaping the rewards of more seniors and disabled people getting access to their medications. British drugmaker GlaxoSmithKline's second-quarter net income grew 14 percent over the same quarter last year due in part to strong Medicare drug sales. Merck & Co., Schering Plough, Wyeth, Roche and Pfizer ... all exceeded analysts' expectations, reflecting sales boosts from the program. In the first three months of the benefit, brand-name drug prices rose 4 percent, according to a report from the AARP. WellPoint Inc., the nation's largest insurer, reported second-quarter profit gains of 34 percent. UnitedHealth ... posted quarterly profit gains of 26 percent. Humana reported earlier this week its second-quarter profit increased 9.9 percent and revenue jumped 52 percent over the same quarter last year, due in large part to a surge in Medicare membership. The insurer expects annual revenue to grow by 50 percent.

Note: This article fails to mention who pays for all these profits -- our tax dollars. To understand the degree of corruption in the pharmaceutical industry, read a two-page summary by one of the most respected MDs in the U.S. at http://www.WantToKnow.info/healthcoverup

Several small, independent automakers are juicing up electric cars. Among the companies trying to lead the charge: Tesla. Tesla Motors...is taking orders for a $100,000 electric high-performance sports car...billed as capable of a Ferrari-like zero to 60 mph in four seconds. The car was designed in California but will be built by Lotus in Great Britain. Its sophisticated lithium-ion battery will allow a range of 250 miles on a single charge and a top speed of 130 mph. Wrightspeed...hopes to produce its own, $100,000 high-performance car within two years. It will have about a 200-mile range. Ian Wright, who heads Wrightspeed...says the new breed of electric cars could have three times the energy efficiency of gas-electric hybrids. "You can build something that's seriously fast and a lot of fun to drive." Zap. At the other end of the performance spectrum...Zap last month started selling a three-wheel electric "city car" imported from China that it says is capable of a top speed of 40 mph. Priced at $9,000, the Xebra has a range of about 40 miles. Tomberlin Group...plans to sell three versions of electric cars. Prices will range from $5,000 for E-Merge E-2 to $8,000 for the four-seat Anvil. The electric revival comes as...Who Killed the Electric Car? has started playing in theaters. The movie alleges that big automakers, oil companies and the government sank promising electric-car technology. The film singles out General Motors for...having created a futuristic electric car that became a Hollywood enviro-darling. When leases ran out, GM collected its Saturn EV1s and sent them to the crusher.

Note: I've heard that Who Killed the Electric Car? is an excellent, revealing film. For lots more on why car mileage has not significantly increased since the days of the Model T (which got 25 miles to the gallon), see http://www.WantToKnow.info/050711carmileageaveragempg

As motorists continue to pay more at the gas pump, two of the nation's largest oil companies on Thursday reported second-quarter profits of nearly $18 billion. The huge profits come at a time when refiners are marking up wholesale gas prices to levels seen during the weeks after Hurricane Katrina, reigniting concerns about the possibility of price gouging. Exxon Mobil Corp. said Thursday that its second-quarter profits increased 36 percent to $10.36 billion, the second-largest quarterly profit ever for a U.S. publicly traded company. Royal Dutch Shell, which operates 155 gas stations in Colorado, reported earnings of $7.32 billion, up 40 percent from a year ago. Including earnings from BP and ConocoPhillips, which reported earlier this week, four of the nation's five largest oil companies netted more than $30 billion in profit during the second quarter. National gross profit margins for refiners have hovered around $21 a barrel this week, compared with about $12 a barrel a year ago. Amid outcry from lawmakers about its profits, the oil industry this week paid for advertisements in 14 newspapers - including The Denver Post, The New York Times and The Washington Post - that insist oil companies' earnings are not exorbitant. The national average price of regular unleaded gasoline is $3 a gallon this week, according to AAA. The price would be about $2.60 a gallon, factoring in taxes and transportation and other costs, if the refiners' gross profit margin had remained at the same levels from a year ago.

Note: At the bottom of this article is an excellent, revealing graph showing the extent of profit margins for oil refiners since January 2005. Very few other major media have been willing to show the hard data in this article.

Drug companies are accused today of endangering public health through widescale marketing malpractices, ranging from covertly attempting to persuade consumers that they are ill to bribing doctors and misrepresenting the results of safety and efficacy tests on their products. In a report that charts the scale of illicit practices by drug companies in the UK and across Europe, Consumers International - the world federation of consumer organisations - says people are not being given facts about the medicines they take because the companies hide the marketing tactics on which they spend billions. "Irresponsible marketing practices form a serious, persistent and widespread problem among the entire pharmaceutical industry," says the report, which analyses the conduct of 20 of the biggest companies. Scandals such as the withdrawal of Vioxx ... show that unethical drug promotion is a consumer concern. Merck withdrew the drug in September 2004, but allegedly knew it could increase the chances of heart attacks and strokes from 2000 and has been accused of manipulating study results to play down the risk. More than 6,000 lawsuits have been filed against the company in the United States by people who claim they suffered heart attacks as a result of the drug. There is no room for complacency when drug companies spend twice as much on marketing as on research...but do not publish information on their drug promotion practices.

Hundreds of protesters gathered outside an exclusive California retreat for government and business leaders Saturday to challenge the right of a "ruling elite" to make policy decisions without public scrutiny. The annual Bohemian Grove retreat has attracted powerful men such as Ronald Reagan, George Bush, former Secretary of State Henry Kissinger, philanthropist David Rockefeller, former West German Chancellor Helmut Schmidt and former House Speaker Newt Gingrich. It's also become a magnet for all types of activists who increasingly use the event to network and organize their campaigns. The men who attend the Bohemian Grove retreat spend two weeks performing plays, eating gourmet camp grub, listening to speakers and power-bonding at the 2,700-acre compound near the Russian River in Sonoma County. The retreat is organized by the exclusive San Francisco-based Bohemian Club. The club and event are shrouded in mystery, much like Yale University's most-famous secret society, Skull and Bones, whose members include President George W. Bush and his presidential rival Sen. John Kerry.

Note: This article strangely has been removed from the San Francisco Chronicle website. To see it in the Internet Archive, click here. For an informative five-minute ABC news clip on the power elite gathering Bohemian Grove reported in 1981, click here. And for reliable information on the most secretive meeting of the world's elite reported by the major media, see our Bilderberg Group compilation available here.

Though the 100 mpg car sounds like a myth, it turns out that such vehicles do exist -- only they're built in your neighbor's garage, not a giant production plant. Known as plug-in hybrid-electric vehicles ... they’re basically Priuses or similar hybrids that have been equipped with extra batteries, so that they rarely use their gasoline engines at all. "People are salivating for plug-ins," says Bradley Berman, editor of the site HybridCars.com. A hybrid vehicle today like a Prius has both a gasoline engine and a battery, which is fed by the braking energy produced by the car. It can’t be plugged in. A plug-in hybrid keeps those components, but essentially gets an extra fuel tank, in the form of an added battery bank ... that allows the car to run exclusively off battery power for most driving. Felix Kramer, founder of the California Cars Initiative, a nonprofit group that promotes the use of high-efficiency, low-emission cars, owns the first consumer plug-in in North America. Not surprisingly, he loves it. "Many days I use no gasoline, because I go at neighborhood speeds for under 30 miles, and I’m just all-electric all day," he says. And the mileage? "At highway speeds, you can easily get over 100 mpg." Other plug-in owners offer up similar results. "I used to fill up every 400 miles or so," he says ... "and now I fill up every 800 miles or so." Advocates estimate that it costs less than $1 per gallon to replenish a plug-in hybrid. "Our goal is to have a $3,000 kit," CalCars' Kramer says. (That number, coincidentally, is also what many plug-in evangelists think that the technology would cost for Toyota to add to its hybrids.)

Note: If people are doing this in their garage, why aren't the auto makers already producing them? In fact, a similar vehicle was produced to be marketed in 2002, but then pulled off the market. To find why average car mileage has remained virtually unchanged for 100 years, click here.

The pharmaceutical industry is beginning to reap a windfall from a surprisingly lucrative niche market: drugs for poor people. The windfall, which by some estimates could be $2 billion or more this year, is a result of the transfer of millions of low-income people into the new Medicare Part D drug program that went into effect in January. Under that program...the prices paid by insurers, and eventually the taxpayer, for the medications given to those transferred are likely to be higher than what was paid under the federal-state Medicaid programs. Analysts expect it to generate hundreds of millions of additional dollars this year for the drug companies. Drugs tend to be cheaper under the Medicaid programs because the states are the buyers and by law they receive the lowest available prices for drugs. But in creating the federal Part D program, Congress -- in what critics saw as a sop to the drug industry -- barred the government from having a negotiating role. The windfall for the drug makers was made possible by a provision of the 2003 Medicare law that exempts Part D drugs from "best price" rebates that the drug makers have been required to give to the state Medicaid programs. Those rebates are meant to make sure that state Medicaid agencies pay no more than the best prices drug companies offer to any big commercial insurer. Now, under Part D, all sorts of price deals will be negotiated by dozens of Medicare drug plans. The prices will be reported to Medicare, but under a provision of the law pushed by industry lobbyists, they will otherwise be kept secret.

For the second time in two months, The Journal of the American Medical Association says it was misled by researchers who failed to reveal financial ties to drug companies. The latest incident, disclosed in letters to the editor and a correction in Wednesday's journal, involves a study showing that pregnant women who stop taking antidepressants risk slipping back into depression. Most of the 13 authors have financial ties to drug companies including antidepressant makers, but only two of them revealed their ties when the study was published in February.

Note: To understand how the drug companies manipulate results and even exert tremendous influence over the U.S. Congress, see http://www.WantToKnow.info/healthcoverup

Chris Paine´s documentary film "Who Killed the Electric Car?" argues convincingly that there was indeed a market for the cars — and a devoted one, ... but that GM [General Motors] squashed the EV1 because, quite simply, it threatened the livelihood of the entire automotive industry. The car used no gasoline, no oil and no mufflers, and it required only sporadic brake maintenance. Each of these components represents billions of dollars in profits for the industry. GM, the oil companies and various government agencies argued that the car wasn´t practical, didn´t have enough range for consumers and was less promising than the apparently imminent hydrogen technology. The reality was exactly the opposite, Paine´s film suggests — the viability of hydrogen as an automotive fuel source alone is in fact almost comically optimistic. The whisper-quiet EV1 was designed by [an] aviation pioneer, Paul MacCready of AeroVironment. In the 1970s, MacCready built the only successful human-powered aircraft, the Gossamer Condor and the Gossamer Albatross. His solar-powered electric car Sunraycer, built for GM, won the 1987 World Solar Challenge Race in Australia. His corporate mantra is "do more with less" — that is, focus on creating vehicles that require less energy to operate, not on finding ways to pump more power into inefficient systems. His team´s battery-powered EV1 was a triumph of engineering and a joy to operate.

Note: For lots more on key suppressed automotive and energy inventions, click here.

Important Note: Explore our full index to key excerpts of revealing major media news articles on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.